<DOC>
	<DOCNO>NCT02671838</DOCNO>
	<brief_summary>Non-adherence medication lead sub-optimal treatment rheumatoid arthritis ( RA ) patient . In order improve disease modify anti-rheumatic drug ( DMARDs ) adherence , investigator conduct randomize control trial test intervention improve medication adherence among low adherers . This intervention involve use musculoskeletal ultrasound program allows RA patient visualize joint inflammation damage real time treatment adherence simultaneously reinforce . In , investigator hope improve patient ' understanding joint disease motivate participant adhere medication .</brief_summary>
	<brief_title>A Musculoskeletal Ultrasound Program Improve Disease Modifying Anti-Rheumatic Drugs Adherence Rheumatoid Arthritis</brief_title>
	<detailed_description>This single center randomize controlled clinical trial conduct Singapore General Hospital . Eligible RA subject meet inclusion exclusion criterion screen use medication adherence measure questionnaire . Thereafter 132 patient low adherers questionnaire recruit randomized ( 1:1 ratio ) either ( ) intervention arm ( musculoskeletal US program ) ( b ) control arm ( without musculoskeletal US program ) , follow period 6 month .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Male female patient 21 75 year old Underlying rheumatoid arthritis diagnose use 1987 2010 RA criterion On least one follow DMARDs ( Methotrexate , Sulfasalazine , Hydroxychloroquine and/or Leflunomide ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>